GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:0072531
|
BP
|
pyrimidine-containing compound transmembrane transport
|
The directed movement of a pyrimidine-containing compound across a membrane. A pyrimidine-containing compound is any compound that contains pyrimidine or a formal derivative thereof.
|
AQP9,
SLC28A3
|
GO:0072537
|
BP
|
fibroblast activation
|
A change in the morphology or behavior of a fibroblast resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
RGCC
|
GO:0072539
|
BP
|
T-helper 17 cell differentiation
|
The process in which a relatively unspecialized T cell acquires the specialized features of a T-helper 17 (Th17) cell. A Th17 cell is a CD4-positive, alpha-beta T cell with the phenotype RORgamma-t-positive that produces IL-17.
|
RORA
|
GO:0072540
|
BP
|
T-helper 17 cell lineage commitment
|
The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a T-helper 17 cell, a CD4-positive, alpha-beta T cell with the phenotype RORgamma-t-positive that produces IL-17.
|
IL6
|
GO:0072553
|
BP
|
terminal button organization
|
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a terminal button. A terminal button is the terminal inflated portion of the axon, containing the specialized apparatus necessary to release neurotransmitters.
|
SNAPIN,
CHD4,
NLGN1
|
GO:0072554
|
BP
|
blood vessel lumenization
|
The process in which a developing blood vessel forms an endothelial lumen through which blood will flow.
|
DLL4
|
GO:0072573
|
BP
|
tolerance induction to lipopolysaccharide
|
Tolerance induction directed at lipopolysaccharide antigens.
|
TNFAIP3
|
GO:0072574
|
BP
|
hepatocyte proliferation
|
The multiplication or reproduction of hepatocytes, resulting in the expansion of a cell population. Hepatocytes form the main structural component of the liver. They are specialized epithelial cells that are organized into interconnected plates called lobules.
|
CEBPB,
RPS6KA1,
PROX1
|
GO:0072576
|
BP
|
liver morphogenesis
|
The process in which the anatomical structures of the liver are generated and organized.
|
CUL3
|
GO:0072577
|
BP
|
endothelial cell apoptotic process
|
Any apoptotic process in an endothelial cell. An endothelial cell comprises the outermost layer or lining of anatomical structures and can be squamous or cuboidal.
|
IL10,
COL4A3,
BMPR2,
MAP3K5
|
GO:0072579
|
BP
|
glycine receptor clustering
|
The receptor clustering process in which glycine receptors are localized to distinct domains in the cell membrane.
|
GPHN
|
GO:0072583
|
BP
|
clathrin-dependent endocytosis
|
An endocytosis process that begins when material is taken up into clathrin-coated pits, which then pinch off to form clathrin-coated endocytic vesicles.
|
HIP1,
PIP5K1C,
AP2A2,
CLTA,
CANX,
AP2S1,
AP2B1,
FCHO2,
PICALM,
FNBP1L,
AP2M1
|
GO:0072584
|
BP
|
caveolin-mediated endocytosis
|
An endocytosis process that begins when material is taken up into plasma membrane caveolae, which then pinch off to form endocytic caveolar carriers.
|
MAPK3,
MAPK1,
CAV1
|
GO:0072592
|
BP
|
oxygen metabolic process
|
The chemical reactions and pathways involving diatomic oxygen (O2).
|
ME3,
FMO2
|
GO:0072593
|
BP
|
reactive oxygen species metabolic process
|
The chemical reactions and pathways involving a reactive oxygen species, any molecules or ions formed by the incomplete one-electron reduction of oxygen. They contribute to the microbicidal activity of phagocytes, regulation of signal transduction and gene expression, and the oxidative damage to biopolymers.
|
CYR61,
NDUFS4,
PDGFB,
BCL2,
VAV1,
NDUFS1,
CTGF,
SESN2,
AOX1,
BNIP3,
PRDX4,
PMAIP1,
PDK4,
NDUFAF2,
RFK,
NOX4,
DDIT4,
NDUFA13,
SESN1
|
GO:0072594
|
BP
|
establishment of protein localization to organelle
|
The directed movement of a protein to a specific location on or in an organelle. Encompasses establishment of localization in the membrane or lumen of a membrane-bounded organelle.
|
LAMP1,
RAB11A,
IFT122
|
GO:0072599
|
BP
|
establishment of protein localization to endoplasmic reticulum
|
The directed movement of a protein to a specific location in the endoplasmic reticulum.
|
RYR2
|
GO:0072600
|
BP
|
establishment of protein localization to Golgi
|
The directed movement of a protein to a specific location in the Golgi apparatus.
|
NRAS
|
GO:0072602
|
BP
|
interleukin-4 secretion
|
The regulated release of interleukin-4 from a cell.
|
NOTCH1,
VTCN1,
IL1RAP
|
GO:0072604
|
BP
|
interleukin-6 secretion
|
The regulated release of interleukin-6 from a cell.
|
LEP
|
GO:0072606
|
BP
|
interleukin-8 secretion
|
The regulated release of interleukin-8 from a cell.
|
CHI3L1,
LEP,
RAB1A
|
GO:0072608
|
BP
|
interleukin-10 secretion
|
The regulated release of interleukin-10 from a cell.
|
F2RL1
|
GO:0072615
|
BP
|
interleukin-17 secretion
|
The regulated release of any member of the interleukin-17 family of cytokines from a cell.
|
NR1H4
|
GO:0072619
|
BP
|
interleukin-21 secretion
|
The regulated release of interleukin-21 from a cell.
|
FOXP1
|
GO:0072643
|
BP
|
interferon-gamma secretion
|
The regulated release of interferon-gamma from a cell.
|
F2RL1,
BTN3A2,
VTCN1,
LILRB1
|
GO:0072655
|
BP
|
establishment of protein localization to mitochondrion
|
The directed movement of a protein to the mitochondrion or a part of the mitochondrion.
|
HK1,
AKT1,
PINK1
|
GO:0072656
|
BP
|
maintenance of protein location in mitochondrion
|
Any process in which a protein is maintained in a specific location in a mitochondrion, and is prevented from moving elsewhere.
|
HK1,
TSPO,
AKT1,
PINK1
|
GO:0072657
|
BP
|
protein localization to membrane
|
A process in which a protein is transported to, or maintained in, a specific location in a membrane.
|
SH3PXD2B,
AP3D1,
RAB29,
CPE,
CAPN3,
TIAM1,
RAB32,
PACSIN1
|
GO:0072659
|
BP
|
protein localization to plasma membrane
|
A process in which a protein is transported to, or maintained in, a specific location in the plasma membrane.
|
FYB,
RAMP1,
RAMP3,
LRP6,
ATP1B1,
RAP2A,
AKT2,
DPP6,
CACNB3,
ATP1B3,
EMP2,
STXBP1,
RAB11A,
RAC1,
ANK2,
FCHO2,
ANK3,
DLG1,
PPIL2,
MAP7,
ADIPOQ,
GPR158,
DENND4C,
PIGW,
C2CD5,
RAPGEF6,
FGF13,
RAB34,
SYTL2,
TNIK,
EPB41L3,
MYO5A
|
GO:0072660
|
BP
|
maintenance of protein location in plasma membrane
|
Any process in which a protein is maintained in a specific location in the plasma membrane, and is prevented from moving elsewhere.
|
ANK3
|
GO:0072661
|
BP
|
protein targeting to plasma membrane
|
The process of directing proteins towards the plasma membrane; usually uses signals contained within the protein.
|
ANXA2,
BSG,
SPTBN1,
ANK2,
ANK3,
PTCH1,
GAS6,
TMED2,
MYADM,
INPP5K,
WNK3,
EHD3
|
GO:0072666
|
BP
|
establishment of protein localization to vacuole
|
The directed movement of a protein to a specific location in a vacuole.
|
TNFAIP3
|
GO:0072672
|
BP
|
neutrophil extravasation
|
The migration of a neutrophil from the blood vessels into the surrounding tissue.
|
PIK3CD,
PIK3CG,
TREM1
|
GO:0072673
|
BP
|
lamellipodium morphogenesis
|
A process that is carried out at the cellular level and in which the structure of a lamellipodium is organized.
|
SNX1,
PLEKHO1,
ABI1,
WASF2
|
GO:0072678
|
BP
|
T cell migration
|
The movement of a T cell within or between different tissues and organs of the body.
|
MYO1G,
S1PR1,
CCL20
|
GO:0072679
|
BP
|
thymocyte migration
|
The movement of a thymocyte through distinct intrathymic niches (e.g. medulla, cortex), where it receives a unique set of developmental cues required for T-cell development.
|
CCL20
|
GO:0072684
|
BP
|
mitochondrial tRNA 3'-trailer cleavage, endonucleolytic
|
Endonucleolytic cleavage of the 3'-end of the pre-tRNA as part of the process of generating the mature 3'-end of the tRNA in the mitochondrion.
|
ELAC2
|
GO:0072697
|
BP
|
protein localization to cell cortex
|
A process in which a protein is transported to, or maintained in, the cell cortex.
|
EZR
|
GO:0072703
|
BP
|
cellular response to methyl methanesulfonate
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methyl methanesulfonate (MMS) stimulus.
|
TP53INP1
|
GO:0072709
|
BP
|
cellular response to sorbitol
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a sorbitol stimulus.
|
MAP2K6
|
GO:0072711
|
BP
|
cellular response to hydroxyurea
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroxyurea stimulus.
|
ATRX,
BLM,
RAD51,
FMR1,
SPIDR
|
GO:0072718
|
BP
|
response to cisplatin
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cisplatin stimulus.
|
NUCB1
|
GO:0072719
|
BP
|
cellular response to cisplatin
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cisplatin stimulus.
|
SLC31A1,
HMOX1,
RAD51,
ADIRF
|
GO:0072750
|
BP
|
cellular response to leptomycin B
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptomycin B stimulus.
|
ID3
|
GO:0072755
|
BP
|
cellular response to benomyl
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a benomyl stimulus.
|
IMPACT
|
GO:0072757
|
BP
|
cellular response to camptothecin
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a camptothecin stimulus.
|
BLM,
RAD51,
SPIDR
|
GO:0075521
|
BP
|
microtubule-dependent intracellular transport of viral material towards nucleus
|
The directed movement of a virus, or part of a virus, towards the host cell nucleus using host microtubules.
|
DYNLT1
|
GO:0075522
|
BP
|
IRES-dependent viral translational initiation
|
Process by which viral mRNA translation is initiated, where a domain in the 5' untranslated region (UTR) of the viral mRNA called an internal ribosome entry site (IRES) binds the host 43S preinitiation complex, circumventing regular cap-dependent translation initiation.
|
SSB,
PTBP1,
EIF3B,
EIF3A
|
GO:0075525
|
BP
|
viral translational termination-reinitiation
|
A process which occurs as part of viral mRNA translation which allows expression of a downstream open reading frame (ORF) in a dicistronic mRNA. In this process, ribosomes translate the upstream ORF but following termination, a proportion of 40S subunits remain tethered to the mRNA and go on to re-initiate translation at the start codon of the downstream ORF.
|
EIF3B,
EIF3A
|
GO:0075713
|
BP
|
establishment of integrated proviral latency
|
A process by which the virus integrates into the host genome and establishes as a stable provirus or prophage.
|
PSIP1,
BANF1,
XRCC5,
HMGA1,
PPIA,
XRCC4
|
GO:0075732
|
BP
|
viral penetration into host nucleus
|
The crossing by the virus of the host nuclear membrane, either as naked viral genome or for small viruses as an intact capsid.
|
KPNA3,
NUP153
|
GO:0075733
|
BP
|
intracellular transport of virus
|
The directed movement of a virus, or part of a virus, within the host cell.
|
VPS37C,
KPNA3,
KPNA4,
XPO1,
KPNA5,
NUPL2,
NMT2,
NUP155,
UBC,
TPR,
NUP62,
NUP153,
RANBP2,
KPNA2,
KPNA1,
NUP107,
RPS27A,
UBA52,
RAE1,
NUP160,
KPNB1,
NUP93,
VPS37A,
NUP43,
NUP37,
NUP35,
NUP210,
NUP205,
SEH1L,
NUP88,
NDC1,
NUP58,
NUP85,
CD209,
NUP50
|
GO:0080009
|
BP
|
mRNA methylation
|
The posttranscriptional addition of methyl groups to specific residues in an mRNA molecule.
|
WTAP,
METTL14
|
GO:0080058
|
BP
|
protein deglutathionylation
|
The protein modification process in which a glutathione molecule is removed from a protein amino acid by breaking a disulfide linkage.
|
GLRX
|
GO:0080111
|
BP
|
DNA demethylation
|
The removal of a methyl group from one or more nucleotides within an DNA molecule.
|
TDG,
ALKBH1,
FTO
|
GO:0080121
|
BP
|
AMP transport
|
The directed movement of AMP, adenosine monophosphate, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
SLC25A17
|
GO:0080129
|
BP
|
proteasome core complex assembly
|
The aggregation, arrangement and bonding together of a mature, active 20S proteasome core particle complex that does not contain any regulatory particles.
|
PSMG1
|
GO:0080154
|
BP
|
regulation of fertilization
|
Any process that modulates the rate, frequency or extent of fertilization. Fertilization is the union of gametes of opposite sexes during the process of sexual reproduction to form a zygote. It involves the fusion of the gametic nuclei (karyogamy) and cytoplasm (plasmogamy).
|
PLCB1
|
GO:0080164
|
BP
|
regulation of nitric oxide metabolic process
|
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water.
|
VIMP
|
GO:0080182
|
BP
|
histone H3-K4 trimethylation
|
The modification of histone H3 by addition of three methyl groups to lysine at position 4 of the histone.
|
OGT,
HIST1H1E,
HIST1H1C,
RTF1,
ZNF335,
KMT2B
|
GO:0085020
|
BP
|
protein K6-linked ubiquitination
|
A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 6 of the ubiquitin monomers, is added to a protein. K6-linked ubiquitination is involved in DNA repair.
|
PARK2,
BRCA1,
UBE2S,
BARD1,
UBE2T,
RNF6,
UBE2D4
|
GO:0085029
|
BP
|
extracellular matrix assembly
|
The aggregation, arrangement and bonding together of the extracellular matrix.
|
TGFB1,
GPM6B,
GAS6,
HAS2
|
GO:0086001
|
BP
|
cardiac muscle cell action potential
|
An action potential that occurs in a cardiac muscle cell.
|
DMD,
PKP2
|
GO:0086002
|
BP
|
cardiac muscle cell action potential involved in contraction
|
An action potential that occurs in a cardiac muscle cell and is involved in its contraction.
|
CACNA2D1,
FGF12,
CACNA1C,
PKP2
|
GO:0086003
|
BP
|
cardiac muscle cell contraction
|
The actin filament-based process in which cytoplasmic actin filaments slide past one another resulting in contraction of a cardiac muscle cell.
|
CAMK2D
|
GO:0086004
|
BP
|
regulation of cardiac muscle cell contraction
|
Any process that modulates the frequency, rate or extent of cardiac muscle cell contraction.
|
PLN,
SRI,
GATA4,
ATP1A2,
STC1,
ANK2,
PDE4D
|
GO:0086005
|
BP
|
ventricular cardiac muscle cell action potential
|
An action potential that occurs in a ventricular cardiac muscle cell.
|
GJA5,
ANK2,
KCNH2,
SNTA1,
RYR2,
NEDD4L,
PKP2
|
GO:0086009
|
BP
|
membrane repolarization
|
The process in which ions are transported across a membrane such that the membrane potential changes in the repolarizing direction, toward the steady state potential. For example, the repolarization during an action potential is from a positive membrane potential towards a negative resting potential.
|
ATP1B1,
ATP1A2,
ATP1B3,
KCNIP2
|
GO:0086010
|
BP
|
membrane depolarization during action potential
|
The process in which membrane potential changes in the depolarizing direction from the negative resting potential towards the positive membrane potential that will be the peak of the action potential.
|
CACNA1G,
YWHAH,
KCNH2,
SCN9A,
CACNA1E,
TPCN2
|
GO:0086011
|
BP
|
membrane repolarization during action potential
|
The process in which ions are transported across a membrane such that the membrane potential changes in the direction from the positive membrane potential at the peak of the action potential towards the negative resting potential.
|
KCNH2
|
GO:0086012
|
BP
|
membrane depolarization during cardiac muscle cell action potential
|
The process in which cardiac muscle cell membrane potential changes in the depolarizing direction from the negative resting potential towards the positive membrane potential that will be the peak of the action potential.
|
ATP1A2,
CACNA2D1,
CACNA1C
|
GO:0086013
|
BP
|
membrane repolarization during cardiac muscle cell action potential
|
The process in which ions are transported across a membrane such that the cardiac muscle cell plasma membrane potential changes in the direction from the positive membrane potential at the peak of the action potential towards the negative resting potential.
|
ATP1B1,
YWHAE,
KCNH2
|
GO:0086014
|
BP
|
atrial cardiac muscle cell action potential
|
An action potential that occurs in an atrial cardiac muscle cell.
|
NUP155,
GJA1,
GJC1,
ANK2
|
GO:0086015
|
BP
|
SA node cell action potential
|
An action potential that occurs in a sinoatrial node cardiac muscle cell.
|
CACNA1G,
GJA5,
ANK2
|
GO:0086016
|
BP
|
AV node cell action potential
|
An action potential that occurs in an atrioventricular node cardiac muscle cell.
|
CACNA1G
|
GO:0086018
|
BP
|
SA node cell to atrial cardiac muscle cell signalling
|
Any process that mediates the transfer of information from an SA node cardiomyocyte to an atrial cardiomyocyte.
|
CACNA1G
|
GO:0086019
|
BP
|
cell-cell signaling involved in cardiac conduction
|
Any process that mediates the transfer of information from one cell to another and contributes to the heart process that regulates cardiac muscle contraction; beginning with the generation of an action potential in the sinoatrial node and ending with regulation of contraction of the myocardium.
|
PKP2
|
GO:0086023
|
BP
|
adrenergic receptor signaling pathway involved in heart process
|
A series of molecular signals beginning with a G-protein coupled adrenergic cell surface receptor combining with epinephrine or norepinephrine, which contributes to a circulatory system process carried out by the heart.
|
PLN,
AKAP13
|
GO:0086024
|
BP
|
adrenergic receptor signaling pathway involved in positive regulation of heart rate
|
An adrenergic receptor signaling pathway that contributes to an increase in frequency or rate of heart contraction. Binding of adrenalin or noradrenalin to a beta-adrenergic receptor on the surface of the signal-receiving cell results in the activation of an intracellular Gs protein. Gs activates adenylate cyclase to increase intracellular cyclic-AMP (cAMP) levels. cAMP binds directly to F-channels to allow an inward flow of sodium (known as funny current, or If current). The funny current is responsible for membrane depolarization and an increase in heart rate.
|
PDE4D
|
GO:0086027
|
BP
|
AV node cell to bundle of His cell signaling
|
Any process that mediates the transfer of information from an AV node cardiac muscle cell to a bundle of His cardiomyocyte.
|
CACNA1G
|
GO:0086029
|
BP
|
Purkinje myocyte to ventricular cardiac muscle cell signaling
|
Any process that mediates the transfer of information from a Purkinje myocyte to a ventricular cardiac muscle cell.
|
RYR2
|
GO:0086036
|
BP
|
regulation of cardiac muscle cell membrane potential
|
Any process that modulates the establishment or extent of a membrane potential in a cardiac muscle cell (a cardiomyocyte). A membrane potential is the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
FXYD1,
ATP2A2,
PLN,
EHD3
|
GO:0086042
|
BP
|
cardiac muscle cell-cardiac muscle cell adhesion
|
The attachment of one cardiomyocyte to another cardiomyocyte via adhesion molecules.
|
DSC2
|
GO:0086045
|
BP
|
membrane depolarization during AV node cell action potential
|
The process in which AV node cardiac muscle cell membrane potential changes in the depolarizing direction from the negative resting potential towards the positive membrane potential that will be the peak of the action potential.
|
CACNA1G,
CACNA1C
|
GO:0086046
|
BP
|
membrane depolarization during SA node cell action potential
|
The process in which SA node cardiac muscle cell membrane potential changes in the depolarizing direction from the negative resting potential towards the positive membrane potential that will be the peak of the action potential.
|
CACNA1G,
ANK2
|
GO:0086053
|
BP
|
AV node cell to bundle of His cell communication by electrical coupling
|
The process that mediates signaling interactions between an AV node cardiomyocyte and a bundle of His cardiac muscle cell by transfer of current between their adjacent cytoplasms via intercellular protein channels.
|
GJA5
|
GO:0086054
|
BP
|
bundle of His cell to Purkinje myocyte communication by electrical coupling
|
The process that mediates signaling interactions between a bundle of His cardiac muscle cell and a Purkinje myocyte by transfer of current between their adjacent cytoplasms via intercellular protein channels.
|
GJA5
|
GO:0086064
|
BP
|
cell communication by electrical coupling involved in cardiac conduction
|
The process that mediates signaling interactions between one cell and another cell by transfer of current between their adjacent cytoplasms via intercellular protein channels and contributes to the process of cardiac conduction.
|
ATP1B1,
GJA1,
PRKACA,
GJA5,
ATP1A2,
CACNA1C,
RYR2,
PKP2
|
GO:0086066
|
BP
|
atrial cardiac muscle cell to AV node cell communication
|
The process that mediates interactions between an atrial cardiomyocyte and its surroundings that contributes to the process of the atrial cardiomyocyte communicating with an AV node cell in cardiac conduction. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment.
|
ANK2
|
GO:0086067
|
BP
|
AV node cell to bundle of His cell communication
|
The process that mediates interactions between an AV node cell and its surroundings that contributes to the process of the AV node cell communicating with a bundle of His cell in cardiac conduction. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment.
|
CXADR
|
GO:0086070
|
BP
|
SA node cell to atrial cardiac muscle cell communication
|
The process that mediates interactions between an SA node cardiomyocyte and its surroundings that contributes to the process of the SA node cardiomyocyte communicating with an atrial cardiomyocyte in cardiac conduction. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment.
|
ANK2
|
GO:0086073
|
BP
|
bundle of His cell-Purkinje myocyte adhesion involved in cell communication
|
The attachment of a bundle of His cell to a Purkinje myocyte via adhesion molecules that results in the cells being juxtaposed so that they can communicate.
|
JUP,
DSP,
DSC2,
DSG2,
PKP2
|
GO:0086091
|
BP
|
regulation of heart rate by cardiac conduction
|
A cardiac conduction process that modulates the frequency or rate of heart contraction.
|
CACNA1G,
JUP,
DSP,
GJA5,
CACNA2D1,
YWHAE,
ANK2,
DSC2,
CAV1,
KCNH2,
CAMK2D,
CACNA1C,
DSG2,
PKP2
|
GO:0086092
|
BP
|
regulation of the force of heart contraction by cardiac conduction
|
A cardiac conduction process that modulates the extent of heart contraction, changing the force with which blood is propelled.
|
PLN
|
GO:0086097
|
BP
|
phospholipase C-activating angiotensin-activated signaling pathway
|
An angiotensin-mediated signaling pathway where the activated receptor transmits the signal via Gq-mediated activation of phospholipase C (PLC). PLC hydrolyses phosphatidylinositol 4,5-bisphosphate (PIP2) into the second messengers inositol-1,4,5,-triphosphate (IP3) and diacylglycerol (DAG). DAG activates protein kinase C (PKC), whilst IP3 binds intracellular receptors to induce the release of Ca2+ from intracellular stores.
|
AGTR1,
ACTN2
|
GO:0086098
|
BP
|
angiotensin-activated signaling pathway involved in heart process
|
An angiotensin receptor signaling pathway which contributes to a circulatory system process carried out by the heart.
|
CAV1
|
GO:0086100
|
BP
|
endothelin receptor signaling pathway
|
A series of molecular signals initiated by an endothelin receptor binding to one of its physiological ligands, and proceeding with the activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. Ends with regulation of a downstream cellular process, e.g. transcription.
|
EDNRA
|
GO:0086103
|
BP
|
G-protein coupled receptor signaling pathway involved in heart process
|
An G-protein coupled receptor signaling pathway which contributes to a circulatory system process carried out by the heart.
|
RAMP3
|
GO:0089700
|
BP
|
protein kinase D signaling
|
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase D, which occurs as a result of a single trigger reaction or compound.
|
PRKD1,
PRKD2
|
GO:0089709
|
BP
|
L-histidine transmembrane transport
|
The directed movement of L-histidine across a membrane.
|
SLC38A1
|